INS and obesity disorder: While these effects have classically been limited to opposing insulin’s effects to maintain euglycemia, the role glucagon plays in amino acid and lipid metabolism as well as maintaining energy homeostasis has identified its effects as potential targets in the treatment of diabetes and obesity.